-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENAS BIOPHARMA - OBEXELIMAB SIGNIFICANTLY LOWERS GLUCOCORTICOID USE AND TOXICITIES IN INDIGO TRIAL

Reuters·06/02/2026 23:05:00

Please log in to view news